Neudle.com: multiple sclerosis environmental factors

Differential
(Click to cross reference)

acetylcholine receptor

acetylcholine receptor antibody

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

activities of daily living

activities of daily living scale

advances in neurology

adverse drug reaction

alemtuzumab

algorithm

alternative medicine

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, Parkinson-dementia-complex

analgesic

anemia

angiography, cerebral

angiography, spinal

anosmia

anterior horn cell disease

anti JC virus antibodies

antibodies to measles

anticoagulant, contraindications

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants, effectiveness

anticonvulsants, selection of

antiviral agents

apraxia

area postrema

area postrema syndrome

arrhythmia, cardiac

arteriovenous malformation, cerebral

atlanto axial dislocation, congenital

autonomic dysfunction

bacterial infection, CNS

Barkhof MR criteria for MS

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavior modification

biologic markers

blacks

bladder dysfunction

blood dyscrasias, neurologic findings with

bone marrow biopsy

bone scanning

bone survey

Borrelia burgdorferi infection

Call-Fleming syndrome

campylobacter infection

cancer, cerebrovascular accident complicating patients with

cannabinoids

carcinoma

cardiovascular disease

CAT scan, abnormal

cavernous sinus, syndrome

central nervous system, infection of

central vein sign

cerebellar atrophy, secondary

cerebellar degeneration

cerebral infarction, hemorrhagic

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, culture of

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, proteincytologic dissociation

cerebrovascular accident

cerebrovascular accident, arterial occlusion, location

cerebrovascular accident, incidence of

cerebrovascular accident, neonatal

cerebrovascular accident, prevention of

cerebrovascular accident, recurrent

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, women

cerebrovascular accident, work up for

cerebrovascular disease

cerebrovascular disease, risk factors in

channelopathy

chemotherapy, CNS treatment and complications with

child abuse

children

chiropractic manipulation

concentration, impaired

confusion

congenital heart disease, CNS complications with

controversies in neurology

corpus callosum, lesion of

cranial neuropathy, multiple

creatine phosphokinase(CPK)elevated

critical care unit

critical illness

cryptococcal meningitis

cytomegalovirus infection

deep gray nuclei

dehydration

delay in diagnosis

delayed muscle relaxation

delirium

delivery, complicated

dementia

demyelinating disease

differential diagnosis

diplopia

disability rating scale, neurological

disability, neurological

disease modifying agents

disseminated intravascular coagulation(DIC)

dizziness

drug abuse

drug holiday

drug induced neurologic disorders

dural arteriovenous malformation

dural sinus thrombosis

dyskinesia

efficacy

electrical injury of nervous system

electroencephalogram, abnormalities of

electroencephalogram, brain mapping

electroencephalogram, periodic complexes

electromyogram

emergencies, neurologic

employment

encephalitis

encephalitis, autoimmune

encephalitis, bornavirus

encephalitis, human immunodeficiency virus type 1

encephalitis, viral

encephalocele

encephalopathy

encephalopathy, metabolic

endemic area

epidemiology of neurology

evidence-based research

exercise

extinction on double simultaneous stimulation

eye movement, painful

fibrinolytic agents, complications

fingolimod

fistula, arterio-venous, dural

fistula, arterio-venous, dural, spinal

gammaglobulin therapy, intravenous

gender

gene

gene mutation

genetic neurologic disorders

gray matter

Guillain Barre syndrome

Guillain Barre syndrome, complications

Guillain Barre syndrome, differential diagnosis of

Guillain Barre syndrome, etiology of

Guillain Barre syndrome, prognosis of

head injury

head injury, management of

head injury, mild

head injury, pediatric

head injury, prognosis in

headache

headache, children

headache, post traumatic

headache, recurrent

headache, severe

headache, thunderclap

heparin, low-molecular-weight

hepatitis B vaccine

heralding manifestation

herniated disc

herniated disc, lumbar

herniated disc, lumbar-conservative vs.surgical treat.of

herniated disc, lumbar-laminectomy

herpes simplex virus

herpes virus

herpes virus infection

herpes zoster

hiccoughs

highly active antiretroviral therapy

Hispanics

HLA

hormone replacement

hospital length of stay

hot bath test

human immunodeficiency virus type 1

human T-lymphotropic virus type I(HTLV-I)

hypertrophic intracranial pachymeningitis

hypotension, systemic

hypothalamus, lesion of

iatrogenic neurologic disorders

imbalance

imbalance, postural

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunization, neurologic complications with

immunocompetent

immunofluorescence

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

inappropriate antidiuretic(A.D.H.)hormone

incidence

inclusion bodies

inclusion bodies, eosinophilic intranuclear

incontinence, fecal

infantile tremor syndrome

infection

infectious mononucleosis

infliximab

intellectual deficit

intellectual deterioration

interferon beta 1-a

intestinal biopsy

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intracranial hemorrhage

Jakob-Creutzfeldt disease

JC virus

Kappa light chain biomarkers

leg weakness, bilateral

levamisole

life expectancy

limbic encephalitis

lipoprotein receptor-related protein 4

low back pain

lumbar spine manipulation

Lyme disease

lymphoma

lymphoma involving CNS

malformation, CNS, congenital

malformation, vascular

malformation, vascular, cerebral

malignancy screen

malpractice

marihuana

McDonald criteria for MS

medical-legal aspects of neurology

medication withdrawal

medulla oblongata

medulla oblongata, lesion of

memory, impairment of

mental status, abnormal

mesial temporal sclerosis

middle cerebellar peduncle

middle cerebellar peduncle, lesion

migraine

migraine, pathogenesis

migraine, prophylaxis

migraine, treatment of

mimics

misdiagnosis

molecular genetics

monoclonal antibodies

monoclonal gammopathy

mononeuropathy

mononeuropathy multiplex

monoparesis

mortality

motor neuron disease

motor neuron disease, juvenile form

movement disorder

movement disorder, psychogenic

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, contrast enhanced, cloud-like

MRI, demyelinating disease

MRI, diffusion weighted

MRI, early changes in CVA

MRI, false negative

MRI, field strength

MRI, field strength, high

MRI, flow void, blood

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, incidental finding

MRI, spinal cord, increased intramedullary cord signal

MRI, T1 weighted high signal foci

multiple sclerosis, aggressive

multiple sclerosis, asymptomatic

multiple sclerosis, children

multiple sclerosis, clinical patterns

multiple sclerosis, cluster

multiple sclerosis, conjugal

multiple sclerosis, conversion to clinically definite

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, epidemiology of

multiple sclerosis, etiology of

multiple sclerosis, familial

multiple sclerosis, lesion location

multiple sclerosis, linoleic acid in

multiple sclerosis, monosymptomatic

multiple sclerosis, pathogenesis

multiple sclerosis, presenting manifestations

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, radiologically isolated syndrome

multiple sclerosis, relapsing

multiple sclerosis, risk factors for

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

myasthenia gravis, classification

myasthenia gravis, diagnosis

myasthenia gravis, etiology of

myasthenia gravis, ocular

myasthenia gravis, receptor site in

myasthenia gravis, seronegative

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myasthenia gravis, variants

myasthenic crisis

myelitis

myelitis, longitudinal

myelitis, transverse

myelitis, transverse, prognosis

myelopathy

myelopathy, ascending

myelopathy, transverse

myopathy, critically ill

myotonia

nabiximols

natalizumab

natalizumab, discontinuation

nausea and vomiting

neoplasm, primary intracerebral

neoplasm, primary of CNS

neoplasm, primary of CNS-children

nerve conduction studies

neuroendocrinology

neurologic complications of, systemic cancer

neurologic disease

neurologic disease, diagnoses of

neurologic examination

neurologic signs

neurologic symptoms

neurologic testing

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromuscular junction, abnormality of

neuromyelitis optica (Devic's disease)

neuromyelitis optica spectrum disorder

neuropathology

neuropathology, brain

neuropathy

neuropathy, painful

neuropathy, sensory

neuroprotective agents

nonsteroidal anti-inflammatory drug

occupational neurologic disorders

old age, neurology of

ophthalmoplegia

ophthalmoplegia, painful

opportunistic infection

opportunistic infection, CNS

optic chiasm

optic chiasm, lesion of

optic nerve, lesion of

optic neuritis

optic neuritis, bilateral

optic neuritis, children

optic neuritis, etiology of

optic neuritis, recurrent

optic neuritis, treatment of

optic neuropathy

oral contraceptives

oral contraceptives, neurologic complications with

organomegaly

orthostatic hypotension

pachymeningitis, cranial

paramagnetic rim lesion, MR

paramyotonia congenita

patient information and support

percussion induced muscle contraction

periaqueductal lesion

perineum, numbness of

periodic paralysis

periodic paralysis, thyrotoxic

pernicious anemia

Persistent postural-perceptual dizziness

personality change

pertussis immunization

plasmapheresis

pleocytosis of cerebrospinal fluid

pneumonia

POEMS syndrome

polymerase chain reaction

polyneuropathy, critically ill

post concussive syndrome

post infectious polyneuropathy

posterior fossa, lesion of

posterior leukoencephalopathy syndrome

postpartum

practice guidelines

precipitating factors

pregnancy, neurologic complications in

premarin

prenatal

prethrombotic state

prevention of neurologic disorders

primary intracranial hypotension

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

proprioception, abnormal

psychological testing

psychomotor retardation

pyramidal tract dysfunction

rapidly fatal neurologic illness

rapidly progressing neurologic illness

recurrent

rehabilitation for neurologic disorders

release phenomena

remote effect of cancer on the nervous system

renal failure

respiratory tract infection

retinal hemorrhages

retinal lesion

retrovirus

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

review article

rheumatoid arthritis

rheumatoid arthritis, neurologic complications of

risk factors

risk stratification

risk-benefit assessment

seizure, drug resistance

seizure, febrile

seizure, focal

seizure, immunization causing

seizure, intractable

seizure, intractable, treatment of

seizure, medication failure

seizure, neonatal

seizure, surgical treatment of

seizure, treatment of

seizure, treatment of, polytherapy

seizure, treatment, adjunctive therapy

selective serotonin reuptake inhibitors

sensory loss

sensory loss, cutaneous

septicemia

serologic testing

serologic testing, false negative

seronegative

seropositive

serotonin agonist

serotonin norepinephrine reuptake inhibitors

sinusitis

skin, lesions in neurologic disorders

sodium channel dysfunction

spasticity

spasticity, treatment of

spina bifida

spinal cord, lesion of

spinal cord, vascular malformation of

spinal manipulation

spirochete infection

status epilepticus

status epilepticus, nonconvulsive

steroid

steroid therapy, CNS treatment and complications with

stimulation, deep brain

stress, emotional

subacute myelo-opticoneuropathy(S.M.O.N.)complex

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subarachnoid hemorrhage

subarachnoid hemorrhage, cerebral convexity

subdural hematoma

subdural hematoma, neonates and infants

suicide

sun exposure

superior sagittal sinus thrombosis

syphilis, diagnosis and treatment

systemic illness

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamus, lesion of-bilateral

tick-borne encephalitis

tissue plasminogen activator, intravenous

Tolosa Hunt syndrome

toxoplasma gondii

toxoplasmosis, acquired

toxoplasmosis, CNS

transient ischemic attack

transient neurologic deficit

trauma

travel, foreign

treatment of neurologic disorder

tremor

trigeminovascular system

triptans

tumor necrosis factor

tumor necrosis factor inhibitor

urinary tract infection

vaccination, neurologic complications with

vaccine

vagus nerve stimulation

varicella zoster virus

vascular malformation, children, intracranial

vasoconstrictive drugs

vasospasm

vasospasm, cerebral

vibratory sensation, abnormal

viral infection

viral infection, CNS

vision, blurred

vision, failure of in childhood

visual field defect

visual loss

visuospatial disturbance

vitamin D

vitamin deficiency

vitamin supplementation

vomiting, intractable

water channel antibodies

weakness

weakness, fatiguable

weakness, generalized

weight loss

wheelchair

white matter disease

white matter disease, periventricular

work loss

yellow fever

zinc

Showing articles 250 to 300 of 6974 << Previous Next >>

Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML
Neurol 77:1061-1067,1033, Tan, I.L.,et al, 2011

Differential Features of Carotid and Vertebral Artery Dissections
Neurol 77:1174-1181, Debette, S.,et al, 2011

Stroke Recurrence within the Time Window Recommended for Carotid Endarterectomy
Neurol 77:738-743, Marrane, M.,et al, 2011

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
Neurol 76:1697-1704, Vermersch,P.,et al, 2011

Clinical and MRI characteristics of acute migrainous infarction
Neurol 76:1911-1917, Wolf, M.E.,et al, 2011

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011

Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurence
Stroke 42:2509-2514, Broderick, J.,et al, 2011

Nonconvulsive Seizures are Common in Critically Ill Children
Neurol 76:1071-1074, Abend,N.S.,et al, 2011

Successful Management of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Syndrome in a Patient With Multiple Sclerosis
Arch Neurol 67:1391-1394, Schr�der,A.,et al, 2010

Recurrent Ischemic Events in Young Adults After First-Ever Ischemic Stroke
Ann Neurol 68:661-671, Putaala,J.,et al, 2010

Safety and Efficacy of Natalizumab in Children With Multiple Sclerosis
Neurol 75:912-917, Ghezzi,A.,et al, 2010

Childhood Posterior Circulation Arterial Ischemic Stroke
Stroke 41:2201-2209, Mackay,M.T.,et al, 2010

Aspirin and Recurrent Intracerebral Hemorrhage in Cerebral Amyloid Angiopathy
Neurol 75:693-698, Biffi,A.,et al, 2010

Prescribing Antiplatelet Medicine and Subsequent Events After Intracerebral Hemorrhage
Stroke 41:2606-2611, Flynn,R.W.V.,et al, 2010

Tourettes Syndrome
NEJM 363:2332-2338, Kurlan,R., 2010

AIDS-Related Lymphomas: Epidemiology, Risk Factors, and Pathobiology
UpToDate, Sept, Kaplan, L.D.,et al, 2010

Migraine with Aura Triggered by Cardiac Myxoma: Case Report and Literature Review
Cephalalgia 30:1396-1399, Ceuster, L.,et al, 2010

Natalizumab and Progressive Multifocal Leukoencephalopathy: What are the Causal Factors and Can It be Avoided?
Arch Neurol 67:923-930, Warnke,C., et al, 2010

Posterior Reversible Encephalopathy Syndrome After Rituximab Infusion in Neuromyelitis Optica
Neurol 74:1471-1473, S�nchez-Carteyron,A., et al, 2010

Severe Cutaneous Candida Infection During Natalizumab Therapy in Multiple Sclerosis
Neurol 74:521-523, Gutwinski,S.,et al, 2010

Intracerebral and Subarachnoid Hemorrhage in Patients with Cancer
Neurol 74:494-501, Navi,B.B.,et al, 2010

Clinicopath Conf, The POEMS Syndrome, with Demyelinating Neuropathy and Solitary Pharmacytoma of Bone
NEJM 362:929-940, Case 7-2010, 2010

Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab
NEJM 361:1075-1080, Wenning,W.,et al, 2009

Intracranial Atherosclerotic Disease: An Update
Ann Neurol 66:730-738, Qureshi,A.,et al, 2009

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 66:403-406, 261, 262, Schweikert,A.,et al, 2009

Seizure Relapse and Development of Drug Resistance Following Long-Term Seizure Remission
Arch Neurol 66:1233-1239, Schiller,Y., 2009

Progressive Multifocal Leukoencephalopathy After Natalizumab Monotherapy
NEJM 361:1081-1087, Linda,H.,et al, 2009

Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009

Human Natural Autoantibodies in the Treatment of Neurologic Disease
Neurol 72:1269-1276, Rodriguez,M.,et al, 2009

Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009

Triple and Quadruple Spontaneous Cervical Artery Dissection: Presenting Characteristics and Long-Term Outcome
JNNP 80:171-174,130, Arnold,M.,et al, 2009

Analysis of 1008 Consecutive Patients Aged 15 to 49 with First-Ever Ischemic Stroke: The Helsinki Young Stroke Registry
Stroke 40:1195-1203, Putaala,J.,et al, 2009

Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009

Immunologic, Clinical, and Radiologic Status 14 Months After Cessation of Natalizumab Therapy
Neurol 72:396-401,392, Stuve,O.,et al, 2009

Natalizumab Use in Pediatric Multiple Sclerosis
Arch Neurol 65:1655-1658, Huppke,P.,et al, 2008

Recurrent Stroke and Massive Right-to-Left Shunt: Results from the Prospective Spanish Multicenter (CODICIA) Study
Stroke 39:3131-3136, Serena,J.,et al, 2008

Treatment of Neuromyelitis Optica with Rituximab; Retrospective Analysis of 25 Patients
Arch Neurol 65:1443-1448, Jacob,A.,et al, 2008

Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008

Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke 39:2644-2691, Roach,E.S.,et al., 2008

Large Artery Intracranial Occlusive Disease: A Large Worldwide Burden But a Relatively Neglected Frontier
Stroke 39:2396-2399, Gorelick,P.B.,et al., 2008

Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008

Restarting Anticoagulation Therapy After Warfarin-Associated Intracerebral Hemorrhage
Arch Neuol 65:1313-1318, Claassen,D.O.,et al, 2008

Hemorrhagic Stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Study
Neurol 70:2364-2370,2355, Goldstein,L.B.,et al, 2008

Sudden Falls Due to Seizure-Induced Cardiac Asystole in Drug-Resistant Focal Epilepsy
Neurol 70:1933-1935, Rubboli,G.,et al, 2008

Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008

B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008

Natalizumab for Multiple Sclerosis
NEJM 356:2622-2629, Ransohoff,R.M., 2007

Multiple Ischemic Strokes Associated With Use of Recombinant Activated Factor VII
Arch Neurol 64:879-881, Libman,R.B.,et al, 2007

Efficacy of Folic Acid Supplementation in Stroke Prevention: A Meta-Analysis
Lancet 369:1876-1882,1841, Wang,X.,et al, 2007

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Showing articles 250 to 300 of 6974 << Previous Next >>